Multicentric Study Comparing Carcinological and Functional Results of Surgery
NCT ID: NCT00502723
Last Updated: 2012-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
1440 participants
INTERVENTIONAL
2007-12-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
Radical laparoscopy prostatectomy
Radical laparoscopy prostatectomy
Radical laparoscopy prostatectomy
1
Radical retropubic prostatectomy
Radical retropubic prostatectomy
Radical retropubic prostatectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radical retropubic prostatectomy
Radical retropubic prostatectomy
Radical laparoscopy prostatectomy
Radical laparoscopy prostatectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* having a prostate cancer proven histologically, requiring a radical prostatectomy.
* Clinical stage T1c and rate of PSA (with 20 ng/ml).
* Osseous scintiscanning and abdomen-pelvic scanner negative.
* Patient informed of the study and its participation.
* Patient affiliated to a social security system.
Exclusion Criteria
* Antecedent of prostate resection or adenomectomy.
* Antecedent of inguinal hernia treatment.
* Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
* Patient privatized of freedom.
18 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claude ABBOU, PU-PH
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Albert Chenevier Henri Mondor
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Claude ABBOU, PU-PH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K060402
Identifier Type: -
Identifier Source: org_study_id